Please assess the completion status of the following clinical trial:

Trial Title: Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* T1 or T2 invasive carcinoma of the breast undergoing breast conserving surgery~* Clinically lymph node negative and Memorial Sloan Kettering nomogram estimates 20% or less risk of positive sentinel node~* Tumors 2.5 cm or less in size (clinical preoperative staging)~* Estrogen receptor positive tumors (≥10%)~* Her2 negative/not over-expressed~* Patients 50 years of age or greater~Exclusion Criteria:~* Prior malignancy not in remission~* Active collagen vascular disease requiring active cytotoxic or immunotherapy~* Psychiatric or mental condition which would preclude informed consent~* Prior thoracic radiation which overlaps with IORT field~* Pregnant patients~* Patients \<50 years~* Risk of positive sentinel lymph node \>20% based on nomogram estimates~* Known lymph node metastases (i.e. clinically node positive)~* Patients with invasive lobular carcinoma~* Patients with pure DCIS~* Known multifocal or multicentric tumor~* Patients requiring neoadjuvant chemotherapy~* Patients requiring or choosing mastectomy with or without reconstruction~* Technical contraindications to IORT dose delivery including skin to balloon distance \<7 mm~* Medical contraindication to IORT, radiation or breast conservation

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).